Fennec Pharmaceuticals (FENC) Non Operating Income (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Non Operating Income of -$2.1 million for Q4 2025, down 373.72% on a QoQ basis from -$449000.0 in Q3 2025, and down 210.06% year-over-year from $1.9 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Non Operating Income (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Non Operating Income history runs 16 years deep, the most recent figure standing at -$2.1 million for Q4 2025.
- Quarterly Non Operating Income fell 210.06% year-over-year to -$2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.4 million (down 27.06% YoY) and the FY2025 annual result came in at -$3.4 million, down 27.06% from the prior year.
- Non Operating Income was -$2.1 million for Q4 2025 at Fennec Pharmaceuticals, down from -$449000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $190000.0 in Q1 2021 and bottomed at -$2.1 million in Q4 2025.
- A 5-year average of -$525700.0 and a median of -$481500.0 in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income soared 2011.11% — and 2022, when it tumbled 1483.33%.
- Fennec Pharmaceuticals' Non Operating Income stood at -$220000.0 in 2021, then sank by 228.18% to -$722000.0 in 2022, then declined by 19.67% to -$864000.0 in 2023, then advanced by 20.6% to -$686000.0 in 2024, then slumped by 210.06% to -$2.1 million in 2025.
- Business Quant data shows FENC's Non Operating Income at -$2.1 million in Q4 2025, -$449000.0 in Q3 2025, and -$420000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | -2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.13 Mn |
| Sep 30, 2025 | -449,000.00 |
| Jun 30, 2025 | -420,000.00 |
| Mar 31, 2025 | -357,000.00 |
| Dec 31, 2024 | -686,000.00 |
| Sep 30, 2024 | -533,000.00 |
| Jun 30, 2024 | -514,000.00 |
| Mar 31, 2024 | -906,000.00 |
| Dec 31, 2023 | -864,000.00 |
| Sep 30, 2023 | -850,000.00 |
| Jun 30, 2023 | -778,000.00 |
| Mar 31, 2023 | -782,000.00 |
| Dec 31, 2022 | -722,000.00 |
| Sep 30, 2022 | -190,000.00 |
| Jun 30, 2022 | -63,000.00 |
| Mar 31, 2022 | -150,000.00 |
| Dec 31, 2021 | -220,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -81,000.00 |
| Mar 31, 2021 | 190,000.00 |